285 related articles for article (PubMed ID: 20559119)
21. Dermatofibrosarcoma protuberans presenting as a subcutaneous mass: a clinicopathological study of 15 cases with exclusive or near-exclusive subcutaneous involvement.
Bague S; Folpe AL
Am J Dermatopathol; 2008 Aug; 30(4):327-32. PubMed ID: 18645303
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
Sachdev R; Sundram U
J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
[TBL] [Abstract][Full Text] [Related]
23. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
Labonte S; Hanna W; Bandarchi-Chamkhaleh B
J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
[TBL] [Abstract][Full Text] [Related]
24. [Extrapleural solitary fibrous tumor with uncommon histology: a clinicopathologic analysis of 7 cases].
Zhao M; Yang ZR; Wang YB; Chen Y; Qi GW; Yan YJ; Xu WJ; Ru GQ; He XL
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):51-56. PubMed ID: 29325251
[No Abstract] [Full Text] [Related]
25. [Dermatofibrosarcoma Darier and Ferrand. Immunohistochemistry study of 38 cases. Research on a specific marker].
Declerck D; Claye C; Rotteleur G; Lecomte-Houcke M
Ann Pathol; 1997 Oct; 17(5):324-8. PubMed ID: 9471146
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous solitary fibrous tumor: a report of 2 cases and review of the literature.
Soldano AC; Meehan SA
Am J Dermatopathol; 2008 Feb; 30(1):54-8. PubMed ID: 18212546
[TBL] [Abstract][Full Text] [Related]
27. Immunoreactivity for the human hematopoietic progenitor cell antigen (CD34) in lipomatous tumors.
Suster S; Fisher C
Am J Surg Pathol; 1997 Feb; 21(2):195-200. PubMed ID: 9042286
[TBL] [Abstract][Full Text] [Related]
28. Sclerosing Dermatofibrosarcoma Protuberans Shows Significant Overlap With Sclerotic Fibroma in Both Routine and Immunohistochemical Analysis: A Potential Diagnostic Pitfall.
Abdaljaleel MY; North JP
Am J Dermatopathol; 2017 Feb; 39(2):83-88. PubMed ID: 28134725
[TBL] [Abstract][Full Text] [Related]
29. A clinical, histologic, and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans.
Maire G; Fraitag S; Galmiche L; Keslair F; Ebran N; Terrier-Lacombe MJ; de Prost Y; Pedeutour F
Arch Dermatol; 2007 Feb; 143(2):203-10. PubMed ID: 17310000
[TBL] [Abstract][Full Text] [Related]
30. A cutaneous case of giant cell angiofibroma occurring with dermatofibrosarcoma protuberans and showing bimodal CD34+ fibroblastic and FXIIIa+ histiocytic immunophenotype.
Silverman JS; Tamsen A
J Cutan Pathol; 1998 May; 25(5):265-70. PubMed ID: 9696292
[TBL] [Abstract][Full Text] [Related]
31. Malignant solitary fibrous tumor: cytopathologic findings and differential diagnosis.
Bishop JA; Rekhtman N; Chun J; Wakely PE; Ali SZ
Cancer Cytopathol; 2010 Apr; 118(2):83-9. PubMed ID: 20209623
[TBL] [Abstract][Full Text] [Related]
32. Spindle cell lipoma-like tumor, solitary fibrous tumor and myofibroblastoma of the breast: a clinico-pathological analysis of 13 cases in favor of a unifying histogenetic concept.
Magro G; Bisceglia M; Michal M; Eusebi V
Virchows Arch; 2002 Mar; 440(3):249-60. PubMed ID: 11889594
[TBL] [Abstract][Full Text] [Related]
33. CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans.
Prieto VG; Reed JA; Shea CR
J Cutan Pathol; 1994 Aug; 21(4):324-9. PubMed ID: 7528229
[TBL] [Abstract][Full Text] [Related]
34. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans.
Goldblum JR
Arch Pathol Lab Med; 1995 Mar; 119(3):238-41. PubMed ID: 7534057
[TBL] [Abstract][Full Text] [Related]
35. Solitary fibrous tumor of the oral cavity with a predominant leiomyomatous-like pattern: A potential diagnostic pitfall.
Amico P; Colella G; Rossiello R; Maria Vecchio G; Leocata P; Magro G
Pathol Res Pract; 2010 Jul; 206(7):499-503. PubMed ID: 20188491
[TBL] [Abstract][Full Text] [Related]
36. Bilateral multiple spindle cell lipomas of the tongue.
Imai T; Michizawa M; Shimizu H; Imai T; Yamamoto N; Yura Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Aug; 106(2):264-9. PubMed ID: 18644522
[TBL] [Abstract][Full Text] [Related]
37. Dermatofibrosarcoma protuberans with EMa+ cells. Report of a case suggesting perineurial cell differentiation.
Zamecnik M; Michal M; Baumruk L; Mukensnabl P
Pathol Res Pract; 2002; 198(11):767-74; discussion 775. PubMed ID: 12530581
[TBL] [Abstract][Full Text] [Related]
38. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Kim HJ; Lee JY; Kim SH; Seo YJ; Lee JH; Park JK; Kim MH; Cinn YW; Cho KH; Yoon TY
Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171
[TBL] [Abstract][Full Text] [Related]
39. Atrophic dermatofibrosarcoma protuberans: an uncommon and misleading variant.
Wu JK; Malik MM; Egan CA
Australas J Dermatol; 2004 Aug; 45(3):175-7. PubMed ID: 15250897
[TBL] [Abstract][Full Text] [Related]
40. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.
Goldblum JR; Tuthill RJ
Am J Dermatopathol; 1997 Apr; 19(2):147-53. PubMed ID: 9129699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
